110 related articles for article (PubMed ID: 32114433)
1. Inhibition of p-mTOR represses PS1 transcription by reducing p-JNK.
Das HK; Hontiveros SS
Front Biosci (Landmark Ed); 2020 Mar; 25(7):1297-1304. PubMed ID: 32114433
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p-mTOR represses transcription of PS1 and Notch 1-signaling.
Das HK; Hontiveros SS
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1172-1183. PubMed ID: 32114428
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal injection of JNK-specific inhibitor SP600125 inhibits the expression of presenilin-1 and Notch signaling in mouse brain without induction of apoptosis.
Rahman M; Zhang Z; Mody AA; Su DM; Das HK
Brain Res; 2012 Apr; 1448():117-28. PubMed ID: 22353755
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.
Lee S; Das HK
Brain Res; 2008 May; 1207():19-31. PubMed ID: 18374905
[TBL] [Abstract][Full Text] [Related]
5. Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations.
Das HK; Tchedre K; Mueller B
J Neurochem; 2012 Aug; 122(3):487-500. PubMed ID: 22607268
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the presenilin-1 gene controls gamma-secretase activity.
Lee S; Das HK
Front Biosci (Elite Ed); 2010 Jan; 2(1):22-35. PubMed ID: 20036849
[TBL] [Abstract][Full Text] [Related]
7. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.
Zhao J; Benakanakere MR; Hosur KB; Galicia JC; Martin M; Kinane DF
Mol Immunol; 2010; 48(1-3):294-304. PubMed ID: 20728939
[TBL] [Abstract][Full Text] [Related]
9. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
Zhou Q; Wang M; Du Y; Zhang W; Bai M; Zhang Z; Li Z; Miao J
Ann Neurol; 2015 Apr; 77(4):637-54. PubMed ID: 25611954
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
[TBL] [Abstract][Full Text] [Related]
14. Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells.
Benoit M; Dormond-Meuwly A; Demartines N; Dormond O
J Surg Res; 2011 May; 167(2):e193-8. PubMed ID: 21324487
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
[TBL] [Abstract][Full Text] [Related]
16. Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation.
Patel MR; Sadiq AA; Jay-Dixon J; Jirakulaporn T; Jacobson BA; Farassati F; Bitterman PB; Kratzke RA
Int J Oncol; 2012 Feb; 40(2):577-82. PubMed ID: 22076560
[TBL] [Abstract][Full Text] [Related]
17. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
Nieminen R; Lahti A; Jalonen U; Kankaanranta H; Moilanen E
Int Immunopharmacol; 2006 Jun; 6(6):987-96. PubMed ID: 16644485
[TBL] [Abstract][Full Text] [Related]
18. Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Webster NJ; Green KN; Settle VJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):161-9. PubMed ID: 15519686
[TBL] [Abstract][Full Text] [Related]
19. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
[TBL] [Abstract][Full Text] [Related]
20. Evidence that enzyme processivity mediates differential Aβ production by PS1 and PS2.
Pintchovski SA; Schenk DB; Basi GS
Curr Alzheimer Res; 2013 Jan; 10(1):4-10. PubMed ID: 22950863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
